The therapeutic dilemma of inclusion body myositis
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
1.
Amato AA, Gronseth GS, Jackson CE, et al. Inclusion body myositis: clinical and pathologic boundaries. Ann Neurol 1996;40:581-586.
2.
Griggs RC, Askanas V, DeMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-713.
3.
Dalakas MC. Polymyositis, dermatomyositis, and inclusion body myositis. N Engl J Med 1991;325:1487-1498.
4.
Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion body myositis: novel findings provide insight into nature of filaments. Arch Neurol 1991;48:1229-1234.
5.
Pruitt JN II, Showalter CJ, Engel AG. Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann Neurol 1996;39:139-143.
6.
Barohn RJ, Amato AA, Sahenk Z, Kissel JT, Mendell JR. Inclusion body myositis: explanation for poor response to immunosuppressive therapy. Neurology 1995;45:1302-1304.
7.
van der Meche FGA, Schmitz PIM, Butch Guillain-Barre Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre Syndrome. N Engl J Med 1992;326:1123-1129.
8.
Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
9.
Soueidan SA, Dalakas MC. Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin. Neurology 1993;43:876-879.
10.
Amato AA, Barohn RJ, Jackson CE, Pappert EJ, Sahenk Z, Kissel JT. Inclusion body myositis: treatment with intravenous immunoglobulin. Neurology 1994;44:1516-1518.
11.
Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion body myositis with IVIG: a double-blind, placebo-control study. Neurology 1997;48:712-716.
12.
Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 1989;320:1592-1597.
13.
Rose MR, Thornton CA, Martens WB, Griggs RC. A natural history study of inclusion-body myositis. Neurology 1996;46:A486.
Information & Authors
Information
Published In
Copyright
Copyright 1997 by Advanstar Communications Inc.
Publication History
Published online: March 1, 1997
Published in print: March 1997
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Inflammatory Myopathies, Neuromuscular Disorders in Clinical Practice, (1355-1368), (2013).https://doi.org/10.1007/978-1-4614-6567-6_65
- Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNFα and rituximab, Clinical Rheumatology, 29, 5, (555-558), (2010).https://doi.org/10.1007/s10067-009-1367-9
- The epidemiology of dermatomyositis in South Australia, APLAR Journal of Rheumatology, 10, 2, (94-100), (2007).https://doi.org/10.1111/j.1479-8077.2007.00267.x
- Autoimmune and Inflammatory Disorders, Textbook of Clinical Neurology, (1155-1184), (2007).https://doi.org/10.1016/B978-141603618-0.10050-5
- Treatment of idiopathic inflammatory myopathies, Current Opinion in Neurology, 16, 5, (569-575), (2003).https://doi.org/10.1097/00019052-200310000-00002
- Inmunoglobulinas endovenosas en las enfermedades autoinmunes sistémicas, Revista Clínica Española, 203, 11, (548-554), (2003).https://doi.org/10.1016/S0014-2565(03)71352-6
- Molecular profiles of inflammatory myopathies, Neurology, 59, 8, (1170-1182), (2002)./doi/10.1212/WNL.59.8.1170
- Tratamiento de la miositis de cuerpos de inclusión, Revista Clínica Española, 202, 6, (329-331), (2002).https://doi.org/10.1016/S0014-2565(02)71068-0
- Acquired Myopathies, Elextrodiagnostic Medicine, (1371-1432), (2002).https://doi.org/10.1016/B978-1-56053-433-4.50036-5
- A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM, Neurology, 56, 3, (323-327), (2001)./doi/10.1212/WNL.56.3.323
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.